Helex
PrivateLast Round
Seed
Oct 30, 2025
Total Funding Raised
$6M
Momentum Score
50 /100
Company Overview
Helex is a biotechnology company developing genomic medicines for high-burden kidney diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Helex Comps
Public and private peers based on sector, stage, and business model.
Helex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 30, 2025 | ||||
| Accelerator | Oct 1, 2021 |
Key People
Founding team and executive leadership
Helex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| pi Ventures | Seed |
| IndieBio | Accelerator |
| Bluehill Capital | Seed |
| SOSV | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2025
$4M raised in Seed round.
Helex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Helex's valuation, stock price, and market status.
